Description: Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are being cured. These are great for individuals and society, but the treatment costs are expensive which is bad for payers and reinsurers. This article explores ways for health reinsurance actuaries to participate in the space and evaluate the risk associated with these treatments

Description: Meditation on life, choices and events during the COVID-19 pandemic

Description: It is with great pleasure that we announce the winner of the “2024 Best Article” in Reinsurance News. Amongst a pool of exceptional articles, the article “What Does the Future of Mortality Look Like?” submitted by Adam Jedynak and Connie Cheng was chosen by the jury as the victorious submission. The article appeared in the June 2024 issue of Reinsurance News. It explores recent shifts in mortality, including post-COVID excess mortality, and looks at the impact of medical advancements and societal changes on mortality.